Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DeCaf-Me delirium prevention trial
ACTRN12621001633875Phase 3Withdrawn
- Sponsor
- Royal Prince Alfred Hospital
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Jet-Alert and melatonin in delirium (4 arms), sponsored by Royal Prince Alfred Hospital. Primary endpoints: Delirium severity by Delirium Rating Scale-Revised-98, Delirium severity by Richmond Agitation and Sedation Scale and 1 more. Planned start Aug 2023; status: withdrawn.
02
Drugs
Jet-Alertmelatonin
03
Conditions
delirium
Beyond the preview
Go deeper on ACTRN12621001633875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001633875.